Literature DB >> 22453238

Insights into Chinese prostate cancer with RNA-seq.

Anirban Sahu1, Matthew K Iyer, Arul M Chinnaiyan.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22453238      PMCID： PMC3343652          DOI： 10.1038/cr.2012.50

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  16 in total

1.  Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population.

Authors:  Jia-hong Chen; Hui-chan He; Fu-neng Jiang; Julia Militar; Petor-yang Ran; Guo-qiang Qin; Chao Cai; Xi-Bin Chen; Jin Zhao; Zi-yao Mo; Yan-ru Chen; Jian-guo Zhu; Xingyin Liu; Wei-de Zhong
Journal:  Med Oncol       Date:  2011-10-30       Impact factor: 3.064

2.  Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.

Authors:  Dorothee Pflueger; Stéphane Terry; Andrea Sboner; Lukas Habegger; Raquel Esgueva; Pei-Chun Lin; Maria A Svensson; Naoki Kitabayashi; Benjamin J Moss; Theresa Y MacDonald; Xuhong Cao; Terrence Barrette; Ashutosh K Tewari; Mark S Chee; Arul M Chinnaiyan; David S Rickman; Francesca Demichelis; Mark B Gerstein; Mark A Rubin
Journal:  Genome Res       Date:  2010-10-29       Impact factor: 9.043

3.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

4.  RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings.

Authors:  Shancheng Ren; Zhiyu Peng; Jian-Hua Mao; Yongwei Yu; Changjun Yin; Xin Gao; Zilian Cui; Jibin Zhang; Kang Yi; Weidong Xu; Chao Chen; Fubo Wang; Xinwu Guo; Ji Lu; Jun Yang; Min Wei; Zhijian Tian; Yinghui Guan; Liang Tang; Chuanliang Xu; Linhui Wang; Xu Gao; Wei Tian; Jian Wang; Huanming Yang; Jun Wang; Yinghao Sun
Journal:  Cell Res       Date:  2012-02-21       Impact factor: 25.617

5.  Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium.

Authors:  Meilin Wang; Fang Liu; Ann W Hsing; Xiang Wang; Qiang Shao; Jun Qi; Yu Ye; Zhong Wang; Hongyan Chen; Xin Gao; Guozeng Wang; Lisa W Chu; Qiang Ding; Jun OuYang; Xu Gao; Yichen Huang; Yanbo Chen; Yu-Tang Gao; Zuo-Feng Zhang; Jiangyu Rao; Rong Shi; Qijun Wu; Yuanyuan Zhang; Haowen Jiang; Jie Zheng; Yanlin Hu; Ling Guo; Xiaoling Lin; Sha Tao; Guangfu Jin; Jielin Sun; Daru Lu; S Lilly Zheng; Yinghao Sun; Zengnan Mo; Changjun Yin; Zhengdong Zhang; Jianfeng Xu
Journal:  Carcinogenesis       Date:  2011-11-23       Impact factor: 4.944

6.  TMPRSS2-ERG gene fusion and clinicopathologic characteristics of Korean prostate cancer patients.

Authors:  Kyoungbun Lee; Ji Youn Chae; Cheol Kwak; Ja Hyeon Ku; Kyung Chul Moon
Journal:  Urology       Date:  2010-08-30       Impact factor: 2.649

7.  Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.

Authors:  Xueying Mao; Yongwei Yu; Lara K Boyd; Guoping Ren; Dongmei Lin; Tracy Chaplin; Sakunthala C Kudahetti; Elzbieta Stankiewicz; Liyan Xue; Luis Beltran; Manu Gupta; R Tim D Oliver; Nick R Lemoine; Daniel M Berney; Bryan D Young; Yong-Jie Lu
Journal:  Cancer Res       Date:  2010-06-01       Impact factor: 12.701

8.  Role of the TMPRSS2-ERG gene fusion in prostate cancer.

Authors:  Scott A Tomlins; Bharathi Laxman; Sooryanarayana Varambally; Xuhong Cao; Jindan Yu; Beth E Helgeson; Qi Cao; John R Prensner; Mark A Rubin; Rajal B Shah; Rohit Mehra; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

Review 9.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

10.  Transcriptome sequencing to detect gene fusions in cancer.

Authors:  Christopher A Maher; Chandan Kumar-Sinha; Xuhong Cao; Shanker Kalyana-Sundaram; Bo Han; Xiaojun Jing; Lee Sam; Terrence Barrette; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962
View more
  3 in total

1.  NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.

Authors:  Chuigong Yu; Guojun Wu; Ruixiao Li; Lei Gao; Fan Yang; Yi Zhao; Jian Zhang; Rui Zhang; Jing Zhang; Libo Yao; Jianlin Yuan; Xia Li
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  A new RNA-seq method to detect the transcription and non-coding RNA in prostate cancer.

Authors:  Xiao-Ming Zhang; Zhong-Wei Ma; Qiang Wang; Jian-Ning Wang; Ji-Wei Yang; Xian-Duo Li; Hao Li; Tong-Yi Men
Journal:  Pathol Oncol Res       Date:  2013-09-17       Impact factor: 3.201

3.  Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity.

Authors:  Malte Krönig; Max Walter; Vanessa Drendel; Martin Werner; Cordula A Jilg; Andreas S Richter; Rolf Backofen; David McGarry; Marie Follo; Wolfgang Schultze-Seemann; Roland Schüle
Journal:  Oncotarget       Date:  2015-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.